# Phio Pharmaceuticals Corp.: Form 8-K, filed Aug 21, 2018

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2018-08-21
- Accepted by EDGAR: Aug 21, 2018, 09:25 ET
- Period: 2018-08-17
- Accession: 0001683168-18-002438
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000168316818002438/rxi_8k-081718.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000168316818002438/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000168316818002438/rxi_8k-081718.htm

Filed Aug 21, 2018.
Source: SEC EDGAR, the filing index for accession 0001683168-18-002438. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
